Cardiac Injury after survived SARS-CoV2-infection (COVID19)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023831

Enrollment

Registered

2021-04-06

Start date

2021-01-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: 1st group: olligosymptomatic and symptomatic patients without severe illness-activity. Not bedridden. No in-hospital stay. No RX/CT-confirmed COVID19-pneumonia, ambulatory treatment. Symptoms

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18-80 years, signed informed consent, 1st SARS-CoV2-Infection (COVID19) confirmed with PCR from nasal and throat swab

Exclusion criteria

Exclusion criteria: Age 80 years, no informed consent, ESKD, dementia, patient with myocarditis/brain infarction/myocardial infarction/cardiac surgery/pacemaker-implantation in the medical history, Patients after heart transplant, congenital heart diseases, re-infection with SARS-CoV2

Design outcomes

Primary

Measure	Time frame
Global ECG- and echocardiographic changes after 3 and 6 months	—

Secondary

Measure	Time frame
Persisting repolarization disorders, persisting depolarization disorders, LV-Dysfunction, Myokarditis	—

Countries

Germany

Contacts

Public ContactDamian Franzen

Franzen Institut

franzen@franzen-institut.de02214201100

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026